bpc-157 for low back pain or back injury evidence BPC-157: What It Is, What We Know, and Why Its Use Arthritis Remains Unproven Biomolecular therapies for chronic discogenic

Its a question that surfaces constantly in research forums, lab discussions, and private consultations

Learn more about Dr

Patients with active cancer, pregnancy, or specific vascular conditions may not be candidates

Its ability to heal unhealable tissues like tendons makes it a powerful tool, but the lack of long-term human safety data means it should be approached with informed caution

CJC-1295 + Ipamorelin This growth hormone secretagogue stack is BHRCs most commonly prescribed protocol for patients over 35 experiencing the natural decline in GH output that begins in the mid-30s

Extra caution is appropriate in patients with active cancer, recent cancer, unexplained masses, unexplained weight loss, pregnancy, breastfeeding, known allergy to peptide products, active infection, immune compromise, significant liver or kidney disease, active inflammatory or autoimmune disease flares, unusual clotting history, uncontrolled cardiovascular disease, use of chemotherapy or immune-modifying biologic therapy, and competitive athletes subject to anti-doping rules